Indegene Ltd. Responds to Trading Volume Inquiry
Indegene Limited addressed a query from the BSE Limited regarding recent movements in the company’s stock price and trading volume. The response, dated March 24, 2026, confirms that as of the communication date, there are no pending information or undisclosed material events likely to significantly impact the company's securities.Indegene Limited noted that the recent market activity appears consistent with broader market conditions and investor sentiment. The company reiterated its commitment to transparent and timely disclosures in compliance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and stated that any significant developments will be communicated as required. Indegene Limited’s stock trades on the BSE under the scrip code 544172.
Srishti Ramesh Kaushik, Company Secretary and Compliance Officer for Indegene Limited, provided the confirmation.
Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Last edited by a moderator: